Dr Reddys Laboratories Ltd share price logo

Dr Reddys Laboratories Ltd

NSE: DRREDDY

BSE: 500124

Large Cap

Pharma Sector

₹1352.00

+7.00

(+0.52%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

What are INDmoney investors doing with Dr Reddys Laboratories shares?

Based on platform-user behaviour - not analyst opinion or company fundamentals.

Search interest on INDmoney

-11%

Searches for Dr Reddys Laboratories on INDmoney have decreased by 11% over the last 30 days.

Investment activity on INDmoney

-13.07%

Investment activity in Dr Reddys Laboratories among INDmoney users has decreased by 13.07% over the last 30 days.

Among the most traded stocks

122nd

Dr Reddys Laboratories was the 122nd most traded stock on INDmoney over the last 7 days.

Average holding period of indmoney investors

55 days

INDmoney investors hold Dr Reddys Laboratories shares for an average of 55 days.

Key Events for Dr Reddys Laboratories

Last Dividend Declared

₹8.00 per share, declared on 12/05/2026

View Dividend History

Dr Reddys Laboratories Stock Performance

as on October 30, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹1,345.00
    ₹1,363.70
    downward going graph

    0.52%

    Downside

    0.87%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹1,101.00
    ₹1,414.90
    downward going graph

    18.57%

    Downside

    4.65%

    Upside

    downward going graph

Dr Reddys Laboratories share price movements today

Previous Close
₹1,345.00
Open
₹1,345.00
Volume
17.14L
Upper Circuit
₹1,392.40
Lower Circuit
₹1,311.40
Day's Low - High
₹1,345.00 - ₹1,363.70
52 Week Low - High
₹1,101.00 - ₹1,414.90

Dr Reddys Laboratories Historical Returns

1 Month Return
+ 11.51 %
3 Month Return
+ 17.15 %
1 Year Return
+ 12.31 %
3 Year Return
+ 25.29 %
5 Year Return
+ 40.06 %

Dr Reddys Laboratories Fundamentals

as on October 30, 2026 at 4:01 pm IST

Market Cap

₹1,12,848.77 Cr

Return on Equity (ROE)

10.69

PE Ratio (TTM)

40.02

Return on capital employed (ROCE)

12.59

Industry PE ratio

51.39

Beta (LTM)

0.58

P/B Ratio

3.32

Dividend Yield

0.64

PEG Ratio

-1.12

Quarterly Earnings Growth YOY

-31.69

EPS (TTM)

49.79

Book Value

455.96

Dr Reddys Laboratories Stock Valuation

as on October 30, 2026 at 4:01 pm IST

Dr Reddys Laboratories in the last 5 years

  • Overview

  • Trends

Lowest (3.37x)

October 27, 2019

Today (40.02x)

October 29, 2026

Industry (51.39x)

October 29, 2026

Highest (53.88x)

December 18, 2020

LowHigh

Today’s Price to Earnings Ratio: 40.02x

Dr Reddys Laboratories Technical Analysis

Track how Dr Reddys Laboratories technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bearish

Moving Averages

Bearish

Neutral

Bullish

Bearish

Oscillators

Bearish

Neutral

Bullish

Neutral

Overall

Bearish10
Bullish1
Neutral4

Oscillators

Name

Value

Action

MACD level (12,26)
-0.69
Bullish
CCI (20)
-50.73
Neutral
RSI (14)
38.62
Neutral
Momentum (10)
0
Neutral
ADI (14)
54.19
Neutral
Ultimate Oscillator (7,14,28)
7.97
Bearish

Moving Averages

Name

Value

Action

SMA (20)
1350.68
Bearish
EMA (20)
1350.71
Bearish
VWMA (20)
1350.33
Bearish
SMA (50)
1352.43
Bearish
EMA (50)
1352.02
Bearish
SMA (200)
1356.33
Bearish
EMA (200)
1354.29
Bearish
KAMA (200)
1352.73
Bearish
DEMA (200)
1354.42
Bearish

Dr Reddys Laboratories Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Dr Reddys Laboratories with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Dr Reddys Laboratories Ltd image
Dr Reddys Laboratories Ltd
HOLD1,12,848.778.01%0.594,15733,700
Divis Laboratories Ltd image
Divis Laboratories Ltd
BUY2,59,628.2716.97%0.522,56810,560
Torrent Pharmaceuticals Ltd image
Torrent Pharmaceuticals Ltd
BUY1,75,478.9143.62%0.872,13819,274
Biocon Ltd image
Biocon Ltd
HOLD57,332.640.21%0.6836816,927
Gland Pharma Ltd image
Gland Pharma Ltd
BUY51,085.71-3.3%0.521,0276,430
See all

Market expectation of Dr Reddys Laboratories Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

HOLD

44.44%

Buy

19.44%

Hold

36.11%

Sell

Dr Reddys Laboratories Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Sales
7,214.8
7,083
7,672.7
8,016.1
8,358.6
8,506
8,545.2
8,804.9
8,727
7,516.2
8,070.5
8,670.8
Other Income
218.9
201
193.1
313.6
154.4
527.6
290.5
330.2
271.1
480
355.5
156.2
Total Income
7,455.7
7,314.8
7,889.2
8,351.8
8,535.6
9,056
8,862.6
9,158.5
9,024.5
8,026.4
8,455.3
8,854
Expenses
5,213.7
5,282.6
5,566.2
5,961.7
6,108.2
6,530.5
6,398.5
6,818.4
6,865.9
7,163.9
7,239.9
6,974.9
Operating Profit
2,001.1
1,800.4
2,106.5
2,054.4
2,250.4
1,975.5
2,146.7
1,986.5
1,861.1
352.3
830.6
1,695.9
Operating Profit Margin %
27.74%
25.42%
27.45%
25.63%
26.92%
23.22%
25.12%
22.56%
21.33%
4.69%
10.29%
19.56%
Profit Before Interest, Tax and Depreciation
2,242
2,032.2
2,323
2,390.1
2,427.4
2,525.5
2,464.1
2,340.1
2,158.6
862.5
1,215.4
1,879.1
Interest
39.4
59.3
59.8
75.7
81.7
65.6
83
90.7
94.4
105.7
125.5
124.8
Depreciation
373.5
367.7
380.6
397
471.4
454.7
476.1
504.6
521
557.1
536.6
526.7
Profit Before Tax
1,829.1
1,605.2
1,882.6
1,917.4
1,874.3
2,005.2
1,905
1,744.8
1,543.2
199.7
553.3
1,227.6
Tax Paid
448.2
295.4
490.2
575.5
470.1
418.5
495.1
408
353.6
-21.6
117.7
314.4
Profit After Tax
1,380.9
1,309.8
1,392.4
1,341.9
1,404.2
1,586.7
1,409.9
1,336.8
1,189.6
221.3
435.6
913.2
Total Net profit including share of profit / Loss from associate company
1,380.9
1,309.8
1,392.4
1,341.9
1,404.2
1,586.7
1,409.9
1,336.8
1,189.6
221.3
435.6
913.2
EPS
82.94
78.66
83.61
75.4
16.97
19.12
17.04
16.18
14.53
2.65
5.33
11.1
Actual EPS
82.94
78.66
83.61
75.4
16.97
19.12
17.04
16.18
14.53
2.65
5.33
11.1
Adjusted EPS
16.59
15.73
16.72
15.08
16.97
19.12
17.04
16.18
14.53
2.65
5.33
11.1
Diluted EPS
82.81
78.53
83.48
75.25
16.94
19.1
17.02
16.18
14.52
2.65
5.33
11.09

Dr Reddys Laboratories Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
14,202.8
15,385.1
17,460
18,972.2
21,439.1
24,587.9
27,916.4
32,553.5
33,593.3
Other Income
155.2
381.3
676.7
339.4
554.7
1,092.5
909
1,119
1,371.8
Total Income
14,436.2
15,829.5
18,193.7
19,386.9
22,099.9
25,762.2
28,920.1
33,762.9
35,072
Expenses
11,929.8
12,270
15,046.6
15,177.6
17,777.5
18,320.7
20,078
24,096.8
27,246.7
Operating Profit
2,273
3,115.1
2,413.4
3,794.6
3,661.6
6,267.2
7,838.4
8,456.7
6,346.6
Operating Profit Margin %
16%
20.25%
13.82%
20%
17.08%
25.49%
28.08%
25.98%
18.89%
Profit Before Interest, Tax and Depreciation
2,506.4
3,559.5
3,147.1
4,209.3
4,322.4
7,441.5
8,842.1
9,666.1
7,825.3
Interest
78.8
88.9
98.3
97
95.8
142.8
171.1
282.9
373.8
Depreciation
1,077.2
1,134.8
1,163.1
1,228.8
1,165.2
1,250.2
1,470
1,703.7
2,058.8
Profit Before Tax
1,350.4
2,335.8
1,885.7
2,883.5
3,061.4
6,048.5
7,201
7,679.5
5,392.7
Tax Paid
438
385.8
-140.3
931.9
878.9
1,541.2
1,623.1
1,954.3
1,235.1
Profit After Tax
912.4
1,950
2,026
1,951.6
2,182.5
4,507.3
5,577.9
5,725.2
4,157.6
Total Net profit including share of profit / Loss from associate company
946.8
1,950
2,026
1,951.6
2,182.5
4,507.3
5,577.9
5,725.2
4,157.6
EPS
57.08
117.53
122.22
117.67
131.57
271.47
335.22
67.89
50.41
Actual EPS
57.08
117.53
122.22
117.67
131.57
271.47
335.22
67.89
50.41
Adjusted EPS
11.42
23.51
24.44
23.53
26.31
54.29
67.04
67.89
50.41
Diluted EPS
56.96
117.33
121.99
117.34
131.21
270.9
334.59
67.79
50.35

Dr Reddys Laboratories Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Net Cash from Operating Activities
3,262.6
2,144.4
1,803
2,870.4
2,984.1
3,570.3
2,810.8
5,887.5
4,543.3
4,642.8
5,673.7
Cash Flow from Investing Activities
-1,609.9
-1,889.6
-1,482.6
-769.2
-494.8
-1,280.6
-1,099.4
-4,108.7
-4,034.2
-5,785.3
-6,425.2
Cash Flow from Financing Activities
-1,700.1
-369.1
-444
-2,132.6
-2,515.9
-29.8
-242.2
-2,686.1
-376.3
1,891.1
829
Net Cash Flow
-47.4
-114.3
-123.6
-31.4
-26.6
1,285.8
3.2
-907.3
132.8
748.6
77.5

Dr Reddys Laboratories Stock Shareholding Pattern

Numbers in percentages

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Promoters
26.65%
26.65%
26.65%
26.64%
26.64%
26.64%
26.64%
26.64%
26.64%
26.63%
26.64%
26.63%
DII
16.21%
18.31%
20.73%
21.48%
22.9%
25.62%
26.74%
27.98%
30.44%
30.72%
31.74%
31.88%
FII
0%
44.49%
42.27%
41.75%
40.08%
37.29%
36.36%
35.52%
33.2%
33.08%
32.07%
31.39%
Public
10.57%
10.38%
10.19%
9.97%
10.22%
10.15%
10%
9.61%
9.47%
9.33%
9.35%
9.9%
Total Outstanding Shares
16,68,09,397
16,68,18,266
16,68,29,701
16,68,76,946
83,44,23,960
83,44,55,365
83,45,81,775
83,46,13,760
83,46,30,355
83,46,56,970
83,46,75,800
83,46,80,285
Total Shareholders
2,57,794
2,55,500
2,67,694
3,10,403
4,03,669
4,59,605
4,51,929
4,49,216
4,55,243
4,49,665
4,46,086
4,76,681

Mutual Funds Buying / Exiting Dr Reddys Laboratories

Holdings as of 15 Oct 2026 · based on the latest SEBI-mandated portfolio disclosures

Mutual Funds Buying Dr Reddys Laboratories

Sorted by largest increase in holding, month-over-month.

Fund Name

Value of Holding

Increase (MoM)

Holding %

ICICI Prudential Healthcare Fund Direct Growth

ICICI Prudential Healthcare Fund Direct Growth

₹732.00 Cr

₹46.89 Cr (+6.84%)

9.73%

Parag Parikh Flexi Cap Direct Growth

Parag Parikh Flexi Cap Direct Growth

₹1,954.73 Cr

₹18.29 Cr (+0.94%)

1.23%

ICICI Prudential Large Cap Fund Direct Plan Growth

ICICI Prudential Large Cap Fund Direct Plan Growth

₹854.39 Cr

₹2.53 Cr (+0.30%)

1.02%

Mutual Funds Exiting Dr Reddys Laboratories

Sorted by largest decrease in holding, month-over-month.

No exiting activity data available right now

No exiting activity data available right now

Dr Reddys Laboratories Corporate Actions

View detailed summary of the earnings and dividend history of Dr Reddys Laboratories.

  • Dr Reddys Laboratories Ltd Earnings Results

    Dr Reddys Laboratories Ltd’s net profit fell -31.35% since last year same period to ₹924.80Cr in the Q2 2026-2027. On a quarterly growth basis, Dr Reddys Laboratories Ltd has generated 108.15% jump in its net profits since last 3-months.

    Read More

  • Dr Reddys Laboratories Ltd Dividends May,2026

    In the quarter ending March 2026, Dr Reddys Laboratories Ltd has declared dividend of ₹8.00 per share on 12 May 2026 - translating a dividend yield of 0.59%.

    Read More about Dividends

Indices Featuring Dr Reddys Laboratories Stock

Check stock indices that include Dr Reddys Laboratories.

NIFTY PHARMA

₹27,124.85

+414.05 (▲1.55%)

Nifty100 Low Volatility 30

₹18,996.60

+103.75 (▲0.55%)

Nifty Healthcare

₹16,449.55

+255.65 (▲1.58%)

BSE MFG

₹1,003.40

-1.19 (▲0.12%)

S&P BSE Dividend Stability

₹982.58

+2.69 (▲0.27%)

S&P BSE 100 LargeCap TMC

₹8,653.71

+14.87 (▲0.17%)

S&P BSE 250 LargeMidCap

₹10,155.34

-8.28 (▲0.08%)

Nifty 200

₹13,183.95

+7.90 (▲0.06%)

NIFTY 50

₹23,053.10

+116.35 (▲0.51%)

NIFTY 100

₹23,971.55

+72.40 (▲0.30%)

Nifty100 Quality

₹5,410.20

+11.75 (▲0.22%)

BSE Healthcare

₹50,168.37

+474.08 (▲0.95%)

BSE 500

₹34,248.59

-103.74 (▲0.30%)

Nifty LargeMidcap 250

₹15,541.55

-47.05 (▲0.30%)

S&P BSE SENSEX 50

₹24,219.04

+85.18 (▲0.35%)

Nifty100 Eq Weig

₹32,416.10

-82.25 (▲0.25%)

S&P BSE 100 ESG

₹389.21

+0.78 (▲0.20%)

BSE 100

₹24,479.83

+36.00 (▲0.15%)

Nifty50 Value 20

₹11,375.55

+64.50 (▲0.57%)

BSE 200

₹10,660.88

-5.83 (▲0.05%)

Nifty 500

₹21,895.90

-45.60 (▲0.21%)

Insights on Dr Reddys Laboratories Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, DRREDDY stock has moved up by 11.5%

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 13.16% to 14.14% in Sep 2026 quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 8.02K Cr → 8.85K Cr (in ₹), with an average increase of 4.8% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, 220.9 Cr → 924.8 Cr (in ₹), with an average increase of 51.1% per quarter

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 9.35% to 9.90% in Sep 2026 quarter

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 26.64% to 26.63% in Sep 2026 quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 20.66% to 20.30% in Sep 2026 quarter

Dr Reddys Laboratories Stock Futures & Options Contracts

View the latest movement in Dr Reddys Laboratories Futures & Options, including strike prices, expiry dates, and percentage changes.

Dr Reddys Laboratories Options

Name
Expiry
Strike Price
LTP
Absolute Change
Change
DRREDDY 23 Nov ₹1360 Call
November 23, 2026
₹1360
₹27.8
2.3
9.02%
DRREDDY 23 Nov ₹1400 Call
November 23, 2026
₹1400
₹12.8
0.7
5.79%
DRREDDY 23 Nov ₹1350 Call
November 23, 2026
₹1350
₹33.4
3.05
10.05%
DRREDDY 23 Nov ₹1380 Call
November 23, 2026
₹1380
₹19.15
1.3
7.28%

Dr Reddys Laboratories Futures

Name
Expiry
Strike Price
LTP
Absolute Change
Change
DRREDDY 23 Nov Fut
November 23, 2026
-
₹1356.9
9.7
0.72%
DRREDDY 29 Dec Fut
December 29, 2026
-
₹1358.9
11.72
0.87%

About Dr Reddys Laboratories Ltd

Dr Reddy's Laboratories Ltd was founded in 1984 and is based in Hyderabad, India. It is a pharmaceutical company that is listed on the Bombay Stock Exchange and National Stock Exchange of India. It has operations in over 60 countries and offers a wide range of products and services in the pharmaceuticals and healthcare sectors. The company has a strong focus on research and development and has over 6,000 employees worldwide.

Dr Reddy's Laboratories Ltd has a diverse portfolio of products and services, including prescription drugs, generic drugs, over-the-counter drugs, active pharmaceutical ingredients, biotechnology products, and nutraceuticals. Its most popular products include antibiotics, anti-infectives, anti-diabetics, anti-cancer, cardiovascular, gastrointestinal, and dermatology products. Some of its popular brands include Omez, Ciprocin, and Revital. It also has a strong presence in the generics market with its brands such as Reditux and Reditux-D.

Revenue: ₹8,670.80Cr as on September 2026 (Q2 FY27)
Net Profit: ₹913.20Cr as on September 2026 (Q2 FY27)
Listing date: 03 Nov, 1994
Chairperson Name: K Satish Reddy
OrganisationDr Reddys Laboratories Ltd
HeadquartersHyderabad
IndustryPharmaceuticals
CEOK Satish Reddy
E-voting on sharesClick here to vote

FAQs

What is Dr Reddys Laboratories share price today?

Dr Reddys Laboratories share price today stands at ₹1352 as on at the close of the market. Dr Reddys Laboratories share today touched a day high of ₹1363.7 and a low of ₹1345.

What is the 52 week high and 52 week low range for Dr Reddys Laboratories share?

Dr Reddys Laboratories touched a 52 week high of ₹1414.9 and a 52 week low of ₹1101. Dr Reddys Laboratories share price today i.e. is closed at ₹1352, which is -4.45% down from its 52 week high and 22.80% up from its 52 week low.

What is Dr Reddys Laboratories's market capitalisation today?

Dr Reddys Laboratories market capitalisation is ₹1,12,848.77 Cr as on .

How to buy Dr Reddys Laboratories shares?

To buy Dr Reddys Laboratories shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for DRREDDY or Dr Reddys Laboratories Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Dr Reddys Laboratories shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Dr Reddys Laboratories trading volume today?

Dr Reddys Laboratories trading volume is 17.14L as on . This means that 17.14L shares of Dr Reddys Laboratories were bought and sold on the stock market during today's trading session.

What are INDmoney investors doing with Dr Reddys Laboratories shares right now?

Based on aggregated, anonymised INDmoney platform data, search interest and investment activity in Dr Reddys Laboratories have both decreased over the past 30 days, and the average INDmoney investor holds the stock for 55 days. This reflects platform activity only and is not investment advice.